Drug Chatter -- Tracking biopharma stock chatter

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

UserTweets
@TickerReport 8
@SleekMoneycom 6
@dakotafinancial 5
@CFinancialNews 5
@emq_news 5

Recent Tweets for FPRX

noritsunagirota @noritsunagirota
Five Prime Therapeutics $FPRX Valuation Declined While Awm Investment Company Has Raised Holding by $600,000 ...
September 25th 2017, 8:09am
TickerReport @TickerReport
Rhumbline Advisers Has $1.03 Million Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/ekIrvD3v7m
September 25th 2017, 4:09am
TickerReport @TickerReport
Rhumbline Advisers Has $1.03 Million Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/ufdVq2pJGR
September 25th 2017, 4:09am
emq_news @emq_news
Rhumbline Advisers Has $1.03 Million Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/9nSPF51OpM
September 25th 2017, 4:09am
dakotafinancial @dakotafinancial
Head-To-Head Survey: Five Prime Therapeutics $FPRX & Dermira $DERM https://t.co/Baz0NCAfLN
September 24th 2017, 5:09pm
SleekMoneycom @SleekMoneycom
BMO Capital Markets Reiterates Hold Rating for Five Prime Therapeutics, Inc. $FPRX https://t.co/MioTffWMJA
September 24th 2017, 9:09am
SPNewsAnalysis @SPNewsAnalysis
Five Prime Therapeutics $FPRX versus Its Rivals Critical Contrast https://t.co/BXDSYf8yPv
September 24th 2017, 5:09am
storminvestor @storminvestor
Five Prime Therapeutics $FPRX versus Its Rivals Critical Contrast https://t.co/7sg8uRsWex
September 24th 2017, 5:09am
dakotafinancial @dakotafinancial
BMO Capital Markets Reiterates Hold Rating for Five Prime Therapeutics, Inc. $FPRX https://t.co/T8tjC3RRbu
September 24th 2017, 3:09am
WatchlistN @WatchlistN
Five Prime Therapeutics, Inc. $FPRX Receives Hold Rating from BMO Capital Markets https://t.co/ycUgZ6QhvY
September 23rd 2017, 1:09pm
TickerReport @TickerReport
ARK Investment Management LLC Buys 10,623 Shares of Five Prime Therapeutics, Inc. $FPRX https://t.co/vDmmk7FsQg
September 23rd 2017, 11:09am
emq_news @emq_news
ARK Investment Management LLC Buys 10,623 Shares of Five Prime Therapeutics, Inc. $FPRX https://t.co/PCadc2Psoc
September 23rd 2017, 11:09am
TickerReport @TickerReport
ARK Investment Management LLC Buys 10,623 Shares of Five Prime Therapeutics, Inc. $FPRX https://t.co/PJxgCyvtzc
September 23rd 2017, 11:09am
intercooleronli @intercooleronli
Five Prime Therapeutics, Inc. $FPRX Stock Rating Reaffirmed by BMO Capital Markets https://t.co/1dBt3khScZ
September 22nd 2017, 4:09pm
CFinancialNews @CFinancialNews
Five Prime Therapeutics, Inc. $FPRX Stock Rating Reaffirmed by BMO Capital Markets https://t.co/6OpVDX1pJ7
September 22nd 2017, 4:09pm
RatingsNetwork @RatingsNetwork
Five Prime Therapeutics's hold rating reiterated at BMO Capital Markets. $39.00 PT. https://t.co/SRGymiGYuY $FPRX #FPRX
September 22nd 2017, 4:09pm
SleekMoneycom @SleekMoneycom
Royal Bank Of Canada Begins Coverage on Five Prime Therapeutics, Inc. $FPRX https://t.co/GZbPsUzfkM
September 22nd 2017, 3:09pm
ARatings @ARatings
Five Prime Therapeutics Gets a Hold Rating from BMO Capital $FPRX https://t.co/3belCBl5k9
September 22nd 2017, 2:09pm
SPNewsAnalysis @SPNewsAnalysis
Contrasting Five Prime Therapeutics $FPRX & Dermira $DERM https://t.co/YU4J1aizOl
September 22nd 2017, 12:09pm
storminvestor @storminvestor
Contrasting Five Prime Therapeutics $FPRX & Dermira $DERM https://t.co/Z7e1Fa4HmH
September 22nd 2017, 12:09pm
chaffeybreeze @chaffeybreeze
BB Biotech AG Has $23.41 Million Stake in Five Prime Therapeutics, Inc. $FPRX https://t.co/IGKVJmEQ3w
September 22nd 2017, 11:09am
IRAMarketReport @IRAMarketReport
BB Biotech AG Has $23.41 Million Stake in Five Prime Therapeutics, Inc. $FPRX https://t.co/lTMkirVfEC
September 22nd 2017, 11:09am
finboxio @finboxio
Five Prime Therapeutics, Inc. $FPRX cashflow analyses imply stock's 39% undervalued https://t.co/NtrZ3NIi01 https://t.co/NbOnf3kWdz
September 22nd 2017, 7:09am
IRAMarketReport @IRAMarketReport
Five Prime Therapeutics, Inc. $FPRX Position Decreased by Zurcher Kantonalbank Zurich Cantonalbank https://t.co/lNX4tk7UW3
September 22nd 2017, 5:09am
chaffeybreeze @chaffeybreeze
Five Prime Therapeutics, Inc. $FPRX Position Decreased by Zurcher Kantonalbank Zurich Cantonalbank https://t.co/Lc16dBldsT
September 22nd 2017, 5:09am
SPNewsAnalysis @SPNewsAnalysis
Head to Head Review: Five Prime Therapeutics $FPRX and Its Rivals https://t.co/UxYsdk74CI
September 22nd 2017, 3:09am
storminvestor @storminvestor
Head to Head Review: Five Prime Therapeutics $FPRX and Its Rivals https://t.co/rMq53a0DFT
September 22nd 2017, 3:09am
GNWLive @GNWLive
Five Prime Therapeutics to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno- $FPRX https://t.co/Zmb9dRRVID
September 21st 2017, 9:09am
SleekMoneycom @SleekMoneycom
Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/ZrmuSdUV8o
September 21st 2017, 7:09am
biotrader98 @biotrader98
RT @jjgiablue: $FPRX-Cowen expects p1 data on cabiralizumab/Opdivo combo at SITC mtg in early Nov. Sees potential in NSCLC and Renal cancer.
September 21st 2017, 7:09am
intercooleronli @intercooleronli
Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/Xps7gN5tIO
September 21st 2017, 6:09am
dakotafinancial @dakotafinancial
Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/6D2XBaLS1P
September 21st 2017, 6:09am
CFinancialNews @CFinancialNews
Five Prime Therapeutics $FPRX & Its Peers Critical Comparison https://t.co/zPf2CVYYzJ
September 21st 2017, 6:09am
SleekMoneycom @SleekMoneycom
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Five Prime Therapeutics $FPRX Share Price https://t.co/fHVf6HZhcY
September 21st 2017, 12:09am
jjgiablue @jjgiablue
$FPRX-Cowen expects p1 data on cabiralizumab/Opdivo combo at SITC mtg in early Nov. Sees potential in NSCLC and Renal cancer.
September 20th 2017, 11:09pm
1LuckyJimmy @1LuckyJimmy
FPRX +0.96 total advance today 10:24 ET. Five Prime Thera $FPRX 36.29 Stock hit a High of 36.50 and 35.33 Low https://t.co/5FsOwuTEqV
September 20th 2017, 11:09am
tgtxdough @tgtxdough
BMO First Look at SITC Titles $FPRX Cabira expect confirmation of late-breaker presentation of Phase 1/2 data for Cabira + Opdivo in October
September 20th 2017, 6:09am
intercooleronli @intercooleronli
Five Prime Therapeutics $FPRX and Its Peers Critical Review https://t.co/F6Zo9fG1hV
September 19th 2017, 2:09pm
dakotafinancial @dakotafinancial
Five Prime Therapeutics $FPRX and Its Peers Critical Review https://t.co/G1H6VQMS9f
September 19th 2017, 2:09pm
CFinancialNews @CFinancialNews
Five Prime Therapeutics $FPRX and Its Peers Critical Review https://t.co/2bA63yf7fq
September 19th 2017, 2:09pm
TheMarketsDaily @TheMarketsDaily
Artal Group S.A. Acquires Shares of 150,000 Five Prime Therapeutics, Inc. $FPRX https://t.co/ilzb195DRV
September 19th 2017, 11:09am
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Shares Sold by Capital Fund Management S.A. https://t.co/R1E1KSmjnM
September 19th 2017, 9:09am
emq_news @emq_news
Five Prime Therapeutics, Inc. $FPRX Shares Sold by Capital Fund Management S.A. https://t.co/VuLwyNFem6
September 19th 2017, 9:09am
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Shares Sold by Capital Fund Management S.A. https://t.co/hCxACsos6q
September 19th 2017, 9:09am
noritsunagirota @noritsunagirota
Five Prime Therapeutics $FPRX At $36.73 Forms Bottom https://t.co/9Da7M0GJdy
September 19th 2017, 6:09am
livetradepro @livetradepro
$FPRX Could go higher but a little leary of that downtrending 200 day moving average. https://t.co/Dg3j2M8A4a
September 19th 2017, 5:09am
biotech_sector @biotech_sector
#FivePrime Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Repor... Read more: https://t.co/809hcmAdVs $FPRX
September 18th 2017, 5:09pm
wosaikeneriki @wosaikeneriki
Five Prime Therapeutics $FPRX Holder Ecor1 Capital Has Upped Its Stake by $605,000 as Shares Declined ...
September 18th 2017, 3:09pm
WatchlistN @WatchlistN
Royal Bank Of Canada Begins Coverage on Five Prime Therapeutics, Inc. $FPRX https://t.co/MLNZ7gqlPn
September 18th 2017, 6:09am
dakotafinancial @dakotafinancial
Five Prime Therapeutics $FPRX Receives Media Impact Score of 0.18 https://t.co/g04mpjCpxa
September 18th 2017, 4:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.